These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37140481)

  • 1. Patient selection for proton therapy using Normal Tissue Complication Probability with deep learning dose prediction for oropharyngeal cancer.
    Huet-Dastarac M; Michiels S; Rivas ST; Ozan H; Sterpin E; Lee JA; Barragan-Montero A
    Med Phys; 2023 Oct; 50(10):6201-6214. PubMed ID: 37140481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
    de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
    Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated clinical decision support system with deep learning dose prediction and NTCP models to evaluate treatment complications in patients with esophageal cancer.
    Draguet C; Barragán-Montero AM; Vera MC; Thomas M; Populaire P; Defraene G; Haustermans K; Lee JA; Sterpin E
    Radiother Oncol; 2022 Nov; 176():101-107. PubMed ID: 36167194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an automated clinical decision system with deep learning dose prediction and NTCP model for prostate cancer proton therapy.
    Chen M; Pang B; Zeng Y; Xu C; Chen J; Yang K; Chang Y; Yang Z
    Phys Med Biol; 2024 May; 69(11):. PubMed ID: 38718814
    [No Abstract]   [Full Text] [Related]  

  • 5. A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
    Rwigema JM; Langendijk JA; Paul van der Laan H; Lukens JN; Swisher-McClure SD; Lin A
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):553-562. PubMed ID: 30625409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
    Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy.
    Stokkevåg CH; Indelicato DJ; Herfarth K; Magelssen H; Evensen ME; Ugland M; Nordberg T; Nystad TA; Hægeland C; Alsaker MD; Ulven K; Dale JE; Engeseth GM; Boer CG; Toussaint L; Kornerup JS; Pettersen HES; Brydøy M; Brandal P; Muren LP
    Acta Oncol; 2019 Oct; 58(10):1416-1422. PubMed ID: 31364899
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy.
    Bijman RG; Breedveld S; Arts T; Astreinidou E; de Jong MA; Granton PV; Petit SF; Hoogeman MS
    Acta Oncol; 2017 Nov; 56(11):1444-1450. PubMed ID: 28828923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-aware 3D U-Net convolutional neural network for knowledge-based planning 3D dose distribution prediction of head-and-neck cancer.
    Osman AFI; Tamam NM
    J Appl Clin Med Phys; 2022 Jul; 23(7):e13630. PubMed ID: 35533234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome after pencil beam scanning proton therapy and dysphagia/xerostomia NTCP calculations of proton and photon radiotherapy delivered to patients with cancer of the major salivary glands.
    Walser MA; Bachmann N; Kluckert J; Köthe A; Tully C; Leiser D; Lomax AJ; Bizzocchi N; Langendijk JA; Weber DC
    Br J Radiol; 2023 Aug; 96(1148):20220672. PubMed ID: 37129312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated Robust Planning for IMPT in Oropharyngeal Cancer Patients Using Machine Learning.
    van Bruggen IG; Huiskes M; de Vette SPM; Holmström M; Langendijk JA; Both S; Kierkels RGJ; Korevaar EW
    Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1283-1290. PubMed ID: 36535432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward automatic beam angle selection for pencil-beam scanning proton liver treatments: A deep learning-based approach.
    Kaderka R; Liu KC; Liu L; VanderStraeten R; Liu TL; Lee KM; Tu YE; MacEwan I; Simpson D; Urbanic J; Chang C
    Med Phys; 2022 Jul; 49(7):4293-4304. PubMed ID: 35488864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning-based automatic proton therapy planning: Impact of post-processing and dose-mimicking in plan robustness.
    Borderias-Villarroel E; Huet Dastarac M; Barragán-Montero AM; Helander R; Holmstrom M; Geets X; Sterpin E
    Med Phys; 2023 Jul; 50(7):4480-4490. PubMed ID: 37029632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
    Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
    Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal tissue complication probability modeling to guide individual treatment planning in pediatric cranial proton and photon radiotherapy.
    Dell'Oro M; Wilson P; Short M; Hua CH; Merchant TE; Bezak E
    Med Phys; 2022 Jan; 49(1):742-755. PubMed ID: 34796509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep learning prediction of proton and photon dose distributions for paediatric abdominal tumours.
    Guerreiro F; Seravalli E; Janssens GO; Maduro JH; Knopf AC; Langendijk JA; Raaymakers BW; Kontaxis C
    Radiother Oncol; 2021 Mar; 156():36-42. PubMed ID: 33264639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the effect of setup uncertainty reduction and adaptation to geometric changes on normal tissue complication probability using online adaptive head and neck intensity modulated proton therapy.
    Lalonde A; Bobić M; Sharp GC; Chamseddine I; Winey B; Paganetti H
    Phys Med Biol; 2023 May; 68(11):. PubMed ID: 37164020
    [No Abstract]   [Full Text] [Related]  

  • 18. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
    Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
    Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partitioning of discrete proton arcs into interlaced subplans can bring proton arc advances to existing proton facilities.
    Engwall E; Marthin O; Wase V; Sundström J; Mikhalev V; de Jong BA; Langendijk JA; Melbéus H; Andersson B; Korevaar EW; Both S; Bokrantz R; Glimelius L; Fredriksson A
    Med Phys; 2023 Sep; 50(9):5723-5733. PubMed ID: 37482909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
    Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
    Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.